| Authors: |
Ishii K; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Davies JS; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Department of Safety Assessment, Genentech Inc., South San Francisco, CA, USA., Sinkoe AL; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Nguyen KA; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Norberg SM; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., McIntosh CP; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Kadakia T; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Precigen, Germantown, MD, USA., Serna C; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Oncology Department, Cell Therapy Unit, AstraZeneca, Gaithersburg, MD, USA., Rae Z; Single Cell Analysis Facility, CCR, NCI, NIH, Bethesda, MD, USA.; 10x Genomics, Pleasanton, CA, USA., Kelly MC; Single Cell Analysis Facility, CCR, NCI, NIH, Bethesda, MD, USA., Hinrichs CS; Center for Immuno-Oncology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Duncan and Nancy MacMillan Center of Excellence in Cancer Immunotherapy and Metabolism, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. |
